Editorial: tofacitinib post-marketing safety reports among ulcerative colitis patients. Veisman I, Ben-Horin S. Aliment Pharmacol Ther 2022;55:131-132.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Veisman I, Ben-Horin S. Editorial: tofacitinib post-marketing safety reports among ulcerative colitis patients. Aliment Pharmacol Ther 2022;55:131-132.
PMID: 34907564